J Korean Orthop Assoc.  1978 Mar;13(1):1-5. 10.4055/jkoa.1978.13.1.1.

Giant Cell Tumor of Bone: It's fate after bone fraft

• Lee HK
• Oh IS
• Limb WS

• KMID: 2460393
• DOI: http://doi.org/10.4055/jkoa.1978.13.1.1

Abstract

Based on clinical, operative and pathological finding in twenty six cases of giant cell tumor, treated by curettage and bone graft in 14 and resection and bone graft in 5 buring 19 years, from 1958 to 1976, following results were obtained. Even in this study, according to others, giant cell tumors were mostly located around the knee in 16 cases. Following up results postoperatively, the overall recurrence rate of giant cell tumor was 38 percent. Especially in curettage and bone graft, it was recurred in 43 percent. Tumor located around the knee and vertebrae showed higher rate of recurrence than those in other sites. Four of the six patients who had an episode of recurrence recurred within the second years, and the other one in the third years after curettage and bone graft. All the two cases who had experienced a second recurrence were resulted in recurrence within second years after curettage and bone graft. Three of six patients treated by curettage and bone graft as secondary treatment had no recurrence.

MeSH Terms

Curettage
Giant Cell Tumor of Bone*
Giant Cell Tumors*
Giant Cells*
Humans
Knee
Recurrence
Spine
Transplants